Visa Inc. (NYSE:V) is one of the 14 Most Promising Fintech Stocks to Invest In. On December 7, HSBC upgraded its rating on Visa Inc. (NYSE:V) from Hold to Buy and raised its price target from $335 to ...
Zoetis Inc. (NYSE:ZTS) is among the 11 Most Oversold S&P 500 Stocks Heading into 2026. On December 10, HSBC slashed its price ...
HSBC shifted its ratings across U.S. large-cap pharmaceuticals in a note on Wednesday, led by Rajesh Kumar, upgrading AbbVie to Buy while cutting Biogen to Reduce, as the bank refreshed its 2026 ...
Shares of InterGlobe Aviation resumed their selling after a one-day hiatus, hurt by the fresh order from the aviation ...
Micron (MU) was in the spotlight on Tuesday as HSBC initiated coverage on the tech company with a Buy rating and $330 price ...
HSBC Holdings' interim chairman Brendan Nelson will move into that role on a permanent basis, in a surprise move that came ...
At the sector level, HSBC expects a modest recovery in IT demand, a pickup in domestic consumption, and stronger credit ...
A top analyst at banking giant HSBC says November's market correction most likely handed bulls an opportunity.
HSBC said Tata Consumer Products' growth portfolio can grow at a Compounded Annual Growth Rate (CAGR) of 26% over financial ...
The bank will boost investment into its branch network by around 30% next year, committing £55.8 million in 2026 ...
On December 10, HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy.
ABP - Live on MSN
HSBC Upgrades India To 'Overweight', Retains Sensex Target Of 94,000 For 2026 Amid Strong Growth Outlook
New Delhi, Dec 11: Indian equities are set to be in a stronger position in 2026 on the back of lower inflation, tax reforms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results